This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: California Institute of Technology. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Anh H Pham in Parkinson's Disease Research.
Introduction
Anh H Pham is an accomplished inventor based in Pasadena, CA (US). She has made significant contributions to the field of biomedical research, particularly in the study of Parkinson's disease. Her innovative work has led to the development of a unique animal model that aids in understanding this debilitating condition.
Latest Patents
Anh H Pham holds a patent for a transgenic mouse that features a genome with a homozygous disruption of the endogenous MFN2 gene expression in dopaminergic neurons. This animal model is specifically designed for Parkinson's disease research, as the disruption of the Mfn2 gene results in severe movement disorders. The model reflects the progressive degeneration of the nigrostriatal circuit, which is characteristic of Parkinson's disease. This innovative approach provides a suitable platform for studying the disease and testing potential treatments.
Career Highlights
Anh H Pham is affiliated with the California Institute of Technology, where she conducts her research. Her work has garnered attention for its potential to advance the understanding of Parkinson's disease and improve therapeutic strategies. With her expertise, she continues to contribute to the scientific community and enhance the quality of life for those affected by this condition.
Collaborations
Anh H Pham collaborates with David C Chan, among others, to further her research initiatives. Their combined efforts aim to explore the complexities of neurodegenerative diseases and develop innovative solutions.
Conclusion
Anh H Pham's contributions to Parkinson's disease research through her innovative patent and collaborative efforts highlight her dedication to advancing medical science. Her work not only enhances our understanding of the disease but also paves the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
